Literature DB >> 2057913

Relationships of plasma viscosity, coagulation and fibrinolysis to coronary risk factors and angina.

G D Lowe1, D A Wood, J T Douglas, R A Riemersma, C C Macintyre, T Takase, E G Tuddenham, C D Forbes, R A Elton, M F Oliver.   

Abstract

Plasma viscosity, molecular markers of activated coagulation and fibrinolysis (fibrinopeptides A and B beta 15-42), coagulation factors (fibrinogen and factor VII) and antiplasmins were measured in 529 men aged 35-54 years and related to new angina pectoris (n = 117) and to coronary risk factors in controls without angina (n = 412). Five major risk factors (cigarette-smoking, blood pressure, cholesterol, triglyceride and body mass index) were each associated with increases in plasma viscosity, coagulation factors, and imbalance of coagulation over fibrinolysis (increased ratio of fibrinopeptide A/fibrinopeptide B beta 15-42). Increased viscosity and fibrinogen in smokers were partly reversed in ex-smokers, but the imbalance of coagulation and fibrinolysis persisted. Cholesterol and triglyceride were also associated with increased antiplasmin activity. In men with angina, only fibrinogen was elevated compared to controls. We suggest that increased plasma viscosity and an imbalance of coagulation over fibrinolysis may be mechanisms by which known risk factors promote arterial thrombosis, but are not present in stable angina.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2057913

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  3 in total

Review 1.  Obstructive sleep apnea syndrome: blood viscosity, blood coagulation abnormalities, and early atherosclerosis.

Authors:  Domenico Maurizio Toraldo; Francesco Peverini; Michele De Benedetto; Francesco De Nuccio
Journal:  Lung       Date:  2012-10-18       Impact factor: 2.584

2.  Homocysteine and fibrinogen changes with L-thyroxine in subclinical hypothyroid patients.

Authors:  Başak Cakal; Erman Cakal; Berrin Demirbaş; Mesut Ozkaya; Selma Karaahmetoğlu; Rüştü Serter; Yalçin Aral
Journal:  J Korean Med Sci       Date:  2007-06       Impact factor: 2.153

3.  Haemostatic changes and thromboembolic risk during tamoxifen therapy in normal women.

Authors:  A L Jones; T J Powles; J G Treleaven; J F Burman; M C Nicolson; H I Chung; S E Ashley
Journal:  Br J Cancer       Date:  1992-10       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.